According to Voyager Therapeutics
's latest financial reports the company has S$0.30 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | S$0.36 B | 18.88% |
2023-12-31 | S$0.30 B | 91.38% |
2022-12-31 | S$0.15 B | -11.08% |
2021-12-31 | S$0.17 B | -25.23% |
2020-12-31 | S$0.23 B | -36.86% |
2019-12-31 | S$0.37 B | 78.32% |
2018-12-31 | S$0.21 B | -5.86% |
2017-12-31 | S$0.22 B | -10.43% |
2016-12-31 | S$0.25 B | -8.17% |
2015-12-31 | S$0.27 B | 2857.26% |
2014-12-31 | S$9.29 M | 5334.69% |
2013-12-31 | S$0.17 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | S$0.26 B | -13.68% | ๐บ๐ธ USA |